Community-onset urosepsis: incidence and risk factors for 30-day mortality – a retrospective cohort study

References

• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304–377.
   PubMed Web of Science ®Google Scholar
• Global report on the epidemiology and burden of sepsis: current evidence, identifying gaps and future directions. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
   Google Scholar
• Bauer M, Gerlach H, Vogelmann T, et al. Mortality in sepsis and septic shock in Europe, North america and Australia between 2009 and 2019-results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239.
   PubMed Web of Science ®Google Scholar
• Vucelic V, Klobucar I, Duras-Cuculic B, et al. Sepsis and septic shock – an observational study of the incidence, management, and mortality predictors in a medical intensive care unit. Croat Med J. 2020;61(5):429–439.
   PubMed Web of Science ®Google Scholar
• Levy MM, Artigas A, Phillips GS, et al. Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919–924.
   PubMed Web of Science ®Google Scholar
• Wagenlehner FM, Weidner W, Naber KG. Optimal management of urosepsis from the urological perspective. Int J Antimicrob Agents. 2007;30(5):390–397.
   PubMed Web of Science ®Google Scholar
• Bonkat G, Cai T, Veeratterapillay R, et al. Management of urosepsis in 2018. Eur Urol Focus. 2019;5(1):20–28.
   PubMedGoogle Scholar
• Kalra OP, Raizada A. Approach to a patient with urosepsis. J Glob Infect Dis. 2009;1(1):57–63.
   PubMedGoogle Scholar
• Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596.
   PubMed Web of Science ®Google Scholar
• Sorensen SM, Schonheyder HC, Nielsen H. The role of imaging of the urinary tract in patients with urosepsis. Int J Infect Dis. 2013;17(5):e299-303–e303.
   PubMed Web of Science ®Google Scholar
• Bonkat GP, Bartoletti R, et. al. Guidelines on urological infections. 2018. The Netherlands: European Association of UrologyArnhem.
   Google Scholar
• Serniak PS, Denisov VK, Guba GB, et al. The diagnosis of urosepsis. Urol Nefrol. 1990;1990(4):9–13.
   Google Scholar
• Wagenlehner FM, Pilatz A, Weidner W. Urosepsis–from the view of the urologist. Int J Antimicrob Agents. 2011;38(Suppl):51–57.
   PubMedGoogle Scholar
• Hofmann W. [Urosepsis and uroseptic shock]. Z Urol Nephrol. 1990;83(6):317–324.
   PubMedGoogle Scholar
• Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in enterobacteriaceae bacteraemia: a systematic review and Meta-analysis. J Antimicrob Chemother. 2007;60(5):913–920.
   PubMed Web of Science ®Google Scholar
• Holmbom M, Giske CG, Fredrikson M, et al. 14-Year survey in a swedish county reveals a pronounced increase in bloodstream infections (BSI). Comorbidity – An independent risk factor for both BSI and mortality. PLoS One. 2016;11(11):e0166527.
   PubMed Web of Science ®Google Scholar
• Holmbom M, Moller V, Nilsson LE, et al. Low incidence of antibiotic-resistant bacteria in South-east Sweden: an epidemiologic study on 9268 cases of bloodstream infection. PLoS One. 2020;15(3):e0230501.
   PubMed Web of Science ®Google Scholar
• Wagenlehner FM, Pilatz A, Naber KG, et al. Therapeutic challenges of urosepsis. Eur J Clin Invest. 2008;38(Suppl 2):45–49.
   PubMedGoogle Scholar
• James JM, Testa HJ. Imaging techniques in the diagnosis of urinary tract infection. Curr Opin Nephrol Hypertens. 1994;3(6):660–664.
   PubMedGoogle Scholar
• Kaplan DM, Rosenfield AT, Smith RC. Advances in the imaging of renal infection. Helical CT and modern coordinated imaging. Infect Dis Clin North Am. 1997;11(3):681–705.
   PubMed Web of Science ®Google Scholar
• Kawashima A, Sandler CM, Goldman SM. Imaging in acute renal infection. BJU Int. 2000;86(Suppl 1):70–79.
   PubMedGoogle Scholar
• European Center for Disease Prenvention and Control. Surveillance Atlas of Infectious Diseases. 2017. Available from: https://atlas.ecdc.europa.eu/public/index.aspx.
   Google Scholar
• Swedres-Svarm 2016. Consumption of antibiotics and occurrence of resistance in Sweden. Solna/Uppsala ISSN1650-6332.
   Google Scholar
• Whiles BB, Deis AS, Simpson SQ. Increased time to initial antimicrobial administration Is associated With progression to septic shock in severe sepsis patients. Crit Care Med. 2017;45(4):623–629.
   PubMed Web of Science ®Google Scholar
• Sjosten O, Nilsson J, Herlitz J, et al. The prehospital assessment of patients with a final hospital diagnosis of sepsis: results of an observational study. Australas Emerg Care. 2019;22(3):187–192.
   PubMed Web of Science ®Google Scholar
• Levy MM, Dellinger RP, Townsend SR, et al. The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010;36(2):222–231.
   PubMed Web of Science ®Google Scholar
• Hattori H, Maeda M, Nagatomo Y, et al. Epidemiology and risk factors for mortality in bloodstream infections: a single-center retrospective study in Japan. Am J Infect Control. 2018;46(12):e75–e79.
   PubMed Web of Science ®Google Scholar
• Honda H, Higuchi N, Shintani K, et al. Inadequate empiric antimicrobial therapy and mortality in geriatric patients with bloodstream infection: a target for antimicrobial stewardship. J Infect Chemother. 2018;24(10):807–811.
   PubMed Web of Science ®Google Scholar
• Wagenlehner FM, Lichtenstern C, Weigand MA, et al. [Urosepsis and treatment]. Urologe A. 2010;49(5):618–622.
   PubMedGoogle Scholar